Clinical Trials
3 trialsNCT07123129 2026-01-30
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
NCT03875157 2023-02-27
Study of IBI318 in Participants With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT02978482 2021-08-18
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
AstraZeneca
Phase 1 Completed